Cybin (HELP) Cash from Operations (2020 - 2025)
Cybin (HELP) reported Cash from Operations of 14713997.56 for Q1 2025, up 4.25% on a YoY basis from 14114282.23 in Q1 2024, and up 24.22% quarter-over-quarter from 19416692.09 in Q4 2024.
Cybin (HELP) Cash from Operations (2020 - 2025) Analysis & Trends
Cybin has reported Cash from Operations for 6 years, with the latest figure at 14713997.56 in Q1 2025.
- For the quarter ending Q1 2025, Cash from Operations rose 4.25% year-over-year to 14713997.56; the trailing twelve-month figure through Mar 2025 stood at 72976646.1 (down 43.06% YoY), and the FY2025 full-year result was 72870967.81, down 42.5% from the prior year.
- Cash from Operations for Q1 2025 stood at 14713997.56, up from 19416692.09 in the prior quarter.
- The five-year high for Cash from Operations was 22564152.41 in Q1 2022, with the low at 19897258.85 in Q2 2024.
- Historically, Cash from Operations has averaged 8384774.34 across 5 years, with a median of 10561150.87 in 2021.
- Annual changes were most pronounced in 2021 — Cash from Operations slumped 524.49% — and 2023, when it gained 24.05%.
- Cybin's Cash from Operations stood at 10165808.55 in 2021, then increased by 21.94% to 7935027.37 in 2022, then plunged by 141.07% to 19128774.2 in 2023, then decreased by 1.51% to 19416692.09 in 2024, then gained by 24.22% to 14713997.56 in 2025.
- The last three Cash from Operations figures came in at 14713997.56 (Q1 2025), 19416692.09 (Q4 2024), and 18948697.6 (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Cybin | 75.42 Mn | 75.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -14.71 Mn |
| Mar 31, 2025 | -14.71 Mn |
| Dec 31, 2024 | -19.42 Mn |
| Dec 31, 2024 | -19.42 Mn |
| Sep 30, 2024 | -18.95 Mn |
| Sep 30, 2024 | -18.95 Mn |
| Jun 30, 2024 | -19.90 Mn |
| Jun 30, 2024 | -19.90 Mn |
| Mar 31, 2024 | -15.37 Mn |
| Mar 31, 2024 | -15.37 Mn |
| Dec 31, 2023 | -19.13 Mn |
| Dec 31, 2023 | -19.13 Mn |
| Sep 30, 2023 | -8.55 Mn |
| Sep 30, 2023 | -8.55 Mn |
| Jun 30, 2023 | -7.96 Mn |
| Jun 30, 2023 | -7.96 Mn |
| Feb 28, 2023 | 9.85 Mn |
| Feb 28, 2023 | 9.85 Mn |
| Dec 31, 2022 | -7.94 Mn |
| Dec 31, 2022 | -7.94 Mn |